CD8A and neoplasm: ,39 Most significantly, in vivo experiments showed that the administration of butyrate led to the suppression of STAT1 signaling, down-regulation of PD-L1, and a decrease in infiltration of CD8+ T-cells that resulted in facilitating immune clearance and tumor growth suppression.